Kazia Therapeutics Limited (KZIA)
NASDAQ·Healthcare·Biotechnology
$7.19
+2.71%
Mkt Cap $13.31M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$31.50
Range $25.00 – $40.00
Implied Upside
+338.1%
Consensus $31.50 vs current $7.19
NASDAQ·Healthcare·Biotechnology
$7.19
+2.71%
Mkt Cap $13.31M
No recent rating data.
Price Target (7 analysts)
$31.50
Range $25.00 – $40.00
+338.1%
Consensus $31.50 vs current $7.19